Medical Pharmacology Chapter 33-34:  Anticancer Drugs

Previous Page Next Page

Section Table of Contents

Site Table of Contents

Previous Page Next Page

Section Table of Contents

Site Table of Contents

References

  1. Wellstein A Giaccone G Atkins MB Sausville Chapter 66:  Cytotoxic Drugs in Goodman & Gilman's:  The Pharmacological Basis of Therapeutics, 13e, Brunton LL Hilal-Dandan R Knollmann BC, eds) 2018.

  2. Sausville EA Longo DL Chapter 103e Principles of Cancer Treatment, in Harrison's Online   (Dennis L. Kasper, Anthony S. Fauci, Stephen L. Hauser, Dan L. Longo,  J. Larry Jameson, Joseph Loscalzo, Eds.),  Harrison's Principles of Internal Medicine, 19th edition, The McGraw-Hill Companies, Inc. 2015.

  3. Chu E  Cancer Chemotherapy Chapter 54 in Basic & Clinical Pharmacology, 14 e (Katzung BG The McGraw-Hill Companies, 2018 (on-line edition)

  4. Tew KD Chapter 17:  Alkylating Agents  in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 10e Wolters Kluwer Health 2015.

  5. Collins JM Cancer Pharmacology Chapter 29 in Abeloff's Clinical Oncology (Niederhuber JE Armitage JO Doroshow JH Kastan MB Tepper JE, eds)  5e Elsevier Churchill Livingstone, Philadelphia, PA 2014.

  6. SEER Training Modules, National Cancer Institute, Types of Chemotherapy Drugs:  Alkylating agents http://training.seer.cancer.gov/treatment/chemotherapy/types.html accessed April 10, 2016.

  7. Roche VF Chapter 37 Cancer and Chemotherapy (in Foye's Principles of Medicinal Chemistry 7e Lemke TL Williams DA Roche VF Zito SW, eds) Wolters Kluwer | Lippincott Williams & Wilkins, 2013.

  8. Roche VF Cancer and Chemotherapy Chapter 37: Therapeutic Classes of Anticancer Drugs-Nitrogen Mustards and Aziridine-Mediated Alkylators. in Foye's Priniciples of Medicinal Chemistry (Lemke TL Williams DA, eds; associate eds, Roche VF Zito SW) 7e Lippinoctt, Williams & Wilkins, a Wolters Kluwer business, 2013.

  9. O'Dwyer PJ Calvert AH   Chapter 18:  Platinum Analogs in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 10e Wolters Kluwer Health 2015.

  10. Cisplatin Drugs.com (access medicine)

  11. Huang JC Zamble DB Reardon JT Lipard SJ Sancar A HMG-somain proteins specifcally inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.  Proc Natl Acad Sci USA 1194 Oct 25:  91(22) 10394-10398. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC45026/

  12. Jawahar Swaminathan and MSD staff at the European Bioinformatics Institute [Public domain], via Wikimedia Commons. DNA mismatch repair protein PMS2, https://commons.wikimedia.org/wiki/File:PDB_1h7u_EBI.jpg

  13. Freyer D Keck School of Medicine UCLA (Rare Disease Report) Cisplatin-associated Hearing Loss in Children-The Past, Present and Future. 49th Congress of the International Society of Paedriatic Oncology (October 12-15, 2017). https://www.youtube.com/watch?v=98T3MLY6lrc

  14. Haas K Introduction to Ctr1:  https://www.youtube.com/watch?v=ufiEZy1so_Y

  15. More SS Akil O Lanculescu AG Geier EG Lustig LR Giacomini KM Role of the Copper Transporter, CTR1, in Platinum-Induced Ototoxicity. Journal of Neuroscience 14 July 2010, 30(28) 9500-9509.

 

This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.  Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information.  Medical or other information  thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.